Steven A. Rosenberg
Affiliations: | NCI/NIH, Bethesda, MD, United States |
Google:
"Steven Rosenberg"Mean distance: 18.94 (cluster 17)
Children
Sign in to add trainee| Sadik H Kassim | research scientist | (Cell & Gene Therapy Tree) | |
| Yutaka Kawakami | research scientist | NCI/NIH |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Mikkilineni L, Natrakul DA, Lam N, et al. (2023) Rapid anti-myeloma activity by T cells expressing an anti-BCMA CAR with a human heavy-chain-only antigen-binding domain. Molecular Therapy : the Journal of the American Society of Gene Therapy |
| Yossef R, Krishna S, Sindiri S, et al. (2023) Phenotypic signatures of circulating neoantigen-reactive CD8 T cells in patients with metastatic cancers. Cancer Cell |
| Parikh AY, Masi R, Gasmi B, et al. (2023) Using patient-derived tumor organoids from common epithelial cancers to analyze personalized T-cell responses to neoantigens. Cancer Immunology, Immunotherapy : Cii |
| Chatani PD, Lowery FJ, Parikh NB, et al. (2023) Cell surface marker-based capture of neoantigen-reactive CD8 T-cell receptors from metastatic tumor digests. Journal For Immunotherapy of Cancer. 11 |
| White BS, Sindiri S, Hill V, et al. (2023) Specific recognition of an fusion by tumor infiltrating lymphocytes from a patient with metastatic cholangiocarcinoma. Journal For Immunotherapy of Cancer. 11 |
| Rosenberg SA, Parkhurst MR, Robbins PF. (2023) Adoptive cell transfer immunotherapy for patients with solid epithelial cancers. Cancer Cell. 41: 646-648 |
| Palmer DC, Webber BR, Patel Y, et al. (2022) Internal checkpoint regulates T cell neoantigen reactivity and susceptibility to PD1 blockade. Med (New York, N.Y.) |
| Kim SP, Vale NR, Zacharakis N, et al. (2022) Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor-Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors. Cancer Immunology Research. OF1-OF15 |
| Seitter SJ, McClelland PH, Ahlman MA, et al. (2022) Durable remissions in two adult patients with Burkitt lymphoma following anti-CD19 CAR T-cell therapy: a single center experience. Leukemia & Lymphoma. 1-5 |
| Leidner R, Sanjuan Silva N, Huang H, et al. (2022) Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer. The New England Journal of Medicine. 386: 2112-2119 |